Does postoperative chemotherapy have a survival benefit for patients with pancreatic cancer?

Journal of Surgical Oncology

Volumn 93, Issue 6, 2006, Pages 485-490

  Tani, Masaji ^a   Kawai, Manabu ^a   Terasawa, Hiroshi ^a   Ina, Shinomi ^a   Hirono, Seiko ^a   Uchiyama, Kazuhisa ^a   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Intra arterial chemotherapy; Invasive ductal carcinoma; Pancreatectomy; Pancreatic cancer; Postoperative chemotherapy

Indexed keywords

FLUOROURACIL; GEMCITABINE; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PANCREAS CARCINOMA; PANCREAS RESECTION; POSTOPERATIVE CARE; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; UNSPECIFIED SIDE EFFECT; CANCER STAGING; INTRAARTERIAL DRUG ADMINISTRATION; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PANCREAS TUMOR; PATHOLOGY;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, PANCREATIC DUCTAL; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; POSTOPERATIVE CARE; SURVIVAL RATE;

EID: 33646826994     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20440     Document Type: Article

References (21)

1. Jemal A, Murray T, Ward E, et al.: Cancer Statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. Matsuno S, Egawa S, Shibuya K, et al.: Pancreatic cancer: Current status of treatment and survival of 16071 patients diagnosed from 1981-1996, using the Japanese National Pancreatic Cancer Database. Int J Clin Oncol 2000;5:153-157.
3. Pedrazzoli S, DiCarlo V, Dionigi R, et al.: Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of head of the pancreas: A multicenter, prospective, randomized study. Ann Surg 1998;228:508-517.
4. Former JG, Kim DK, Cuhilla A, et al.: Regional panereatectomy: En bloc pancreatic, portal vein and lymph node resection. Ann Surg 1977;186:42-50.
5. Former JG, Klimstra DS, Senie RT, et al.: Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy. Ann Surg 1996;223:147-153.
6. Nagakawa T, Nagamori M, Futakami F, et al.: Results of extensive surgery for pancreatic carcinoma. Cancer 1996;77:640-645.
7. Ishikawa O, Ohhigashi H, Sasaki Y, et al.: Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg 1988;208:215-220.
8. Hirata K, Sato T, Mukaiya M, et al.: Results of 1001 pancreatic resections for invasive ductal adenocarcinoma of the pancreas. Arch Surg 1997;132:771-776.
9. Yeo CJ, Sohn TA, Cameron JL, et al.: Periampullary adenocarcinoma: Analysis of 5-year survivors. Ann Surg 1998;227:821-831.
10. Yeo CJ, Cameron JL, Sohn TA, et al.: Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: Pathology, complications, and outcomes. Ann Surg 1997;226:248-257.
11. Yeo CJ, Cameron JL, Sohn TA, et al.: Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma. Comparison of morbidity and mortality and short-term outcome. Ann Surg 1999;229:613-624.
12. Japan Pancreas Society: Classification of pancreatic carcinoma, 2nd English edition. Tokyo: Kanehara; 2003.
13. International Union Against Cancer (UICC): TNM classification of malignant tumors. 6th edition. New York: Wiley-Liss; 2002.
14. Nakao A, Harada A, Nonami T, et al.: Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer. Pancreas 1996;12:357-361.
15. Imamura M, Doi R, Imaizumi T, et al.: A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer. Surgery 2004;136:1003-1011.
16. Yamaue H, Tani M, Onishi H, et al.: Locoregional chemotherapy for patients with pancreatic cancer intra-arterial adjuvant chemotherapy after pancreatectomy with portal vein resection. Pancreas 2002;25:366-372.
17. Ishikawa O, Ohigashi H, Sasaki Y: Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas. Am J Surg 1994;168:361-364.
18. Gastrointestinal Tumor Study Group: Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987;59:2006-2010.
19. Klinkenbijl JH, Jeekel J, Sahmoud T, et al.: Adjuvant radiotherapy and 5-Fluorouracil after curative resection of cancer of the pancreas and periamptillary region. Ann Surg 1999;230:776-784.
20. Neoptplemos JP, Stocken DD, Friess H, et al.: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200-1210.
21. Kawai M, Uchiyama K, Tani M, et al.: Clinicopathological features of malignant intraductal papillary mucinous tumors of the pancreas: The differential diagnosis from benign entities. Arch Surg 2004;139:188-192.